Attached files
| file | filename |
|---|---|
| 10-Q - Benda Pharmaceutical, Inc. | v186380_10q.htm |
| EX-31.1 - Benda Pharmaceutical, Inc. | v186380_ex31-1.htm |
Exhibit
32.1
CERTIFICATION
OF
CHIEF
EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT
TO 18 U.S.C. SECTION 1350
In
connection with this Quarterly Report of Benda Pharmaceutical, Inc. (the
“Company”) on Form 10-Q for the period ending March 31, 2010, as filed
with the Securities and Exchange Commission on the date hereof (the “Report”),
I, Yiqing Wan, President, Chief Executive Officer, Chief Financial and
Accounting Officer and Director of the Company, certifies to the best of his
knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of
the Sarbanes-Oxley Act of 2002, that:
|
1.
|
Such
Quarterly Report on Form 10-Q for the period ending March 31,
2010, fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
|
2.
|
The
information contained in such Quarterly Report on Form 10-Q for
the period ending March 31, 2010, fairly presents, in all
material respects, the financial condition and results of operations of
Benda Pharmaceutical, Inc.
|
|
Date: May
24, 2010
|
||||
|
/s/
Yiqing Wan
|
||||
|
Yiqing
Wan
|
||||
|
President,
CEO and Director
|
|
|||
|
Chief
Financial and Accounting Officer
|